Elastin-laminin receptor and abdominal aortic aneurysms. New subject to study? A review

Pathologie Biologie

Volumn 49, Issue 4, 2001, Pages 333-338

  Kunecki, M ^a   Nawrocka, A ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Abdominal aortic aneurysm; Elastin; Elastin peptides; Elastin laminin receptor

Indexed keywords

ELASTIN; LAMININ RECEPTOR;

ABDOMINAL AORTA ANEURYSM; AGING; ANEURYSM RUPTURE; ANIMAL CELL; ATHEROSCLEROSIS; EXTRACELLULAR MATRIX; HEART CONTRACTION; NONHUMAN; PROTEIN DEGRADATION; RECEPTOR BINDING; REVIEW; TENSILE STRENGTH; VISCOELASTICITY;

EID: 0035010178     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(01)00142-0     Document Type: Review

References (80)

1. Pathogenesis of abdominal aortic aneurysms - Cellular and biochemical mechanisms
2. Pathogenesis of abdominal aneurysm
3. Cellular, enzymatic and genetic factors in the pathogenesis of abdominal aortic aneurysms
4. Mechanics of normal and diseased blood vessels
5. Human abdominal aortic aneurysm is closely associated with compositional and specific structural modifications at the glycosaminoglycan level
6. Abdominal aortic aneurysms are associated with altered matrix proteins of the nonaneurysmal aortic segments
7. The composition and mechanical properties of abdominal aortic aneurysms
8. How fast do very small aneurysms grow?
9. Mortality from aortic aneurysms in migrants between countries of England and Wales: Evidence for causes acting early in life
10. Recommended indications for operative treatment of abdominal aortic aneurysms
11. Wall stress distribution on three-dimensionally reconstructed models of human aortic aneurysm
12. Pathogenic sequence for aneurysm revealed in mice underexpressing fibrillin-1
13. Visceral aneurysms in Ehlers-Danlos syndrome: Case report and review of the literature
14. Copper, lysyl oxidase, and extracellular matrix protein cross-linking
15. Cell-matrix interactions, alterations with aging, involvement in angiogenesis
16. Elastin degradation by matrix metalloproteinases
17. Interaction between cells and elastin, the elastin receptor
18. The elastin receptor shows structural and functional similarities to the 67-kDa tumor cell laminin receptor
19. Biological effects of elastin peptides
20. Human helper and memory lymphocytes exhibit an inducible elastin-laminin receptor
21. Aging and matrix biology
22. Effect of elastin peptides on vascular tone
23. Identification of elastin peptides with vasorelaxant activity on rat thoracic aorta
24. Inducible adhesion of mesenchymal cells to elastic fibres: Elastonectin
25. Nuclear and cytoplasmic free calcium level changes induced by elastin peptides in human endothelial cells
26. 2+ mobilisation stimulation of respiratory burst and enzyme secretion
27. Aging of the vascular wall and atherogenesis: Role of the elastin-laminin receptor
28. Transition of smooth muscle cells from the quiescent to the proliferative form. Role of elastonectin and plasma membrane elastase-type protease
29. Mechanism of aging of the extracellular matrix: Role of the elastin-laminin receptor
30. Age-dependent changes of k-elastin stimulated effector functions of human phagocytic cells: Revelance for atherogenesis
31. Cell death induced in lymphocytes expressing the elastin-laminin receptor by excess agonists: Necrosis and apoptosis
32. Cell death by overload of the elastin-laminin receptor on human activated lymphocytes: Protection of lactose and melibiose
33. Elastin-elastase-atherosclerosis revisited
34. Matrix metalloproteinases
35. Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta
36. Matrix metalloproteinase 2 production and its binding to the matrix are increased in abdominal aortic aneurysms
37. Activated forms of mmP2 and mmP9 in abdominal aortic aneurysms
38. Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease
39. Amlodipine potentiates metalloproteinase activity and accelerates elastin degradation in a model of aneurysmal disease
40. Inflammation and matrix matalloproteinases in the enlarging abdominal aortic aneurysm
41. Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture
42. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall
43. Expression and localization of macrophage elastase (Matrix Metalloproteinase-12) in abdominal aortic aneurysms
44. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
45. Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease
46. The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms
47. Marimastat inhibits elastin degradation and matrix metalloproteinase 2 activity in a model of aneurysm disease
48. Local overexpression of TIMP-1 prevents aortic aneurysm degradation and rupture in rat model
49. Reduced capacity to inhibit elastase in abdominal aortic aneurysm
50. Elastase-induced experimental aneurysms in rats
51. The elastase infusion model of experimental aortic aneurysms: Synchrony of induction of endogenous proteinases with matrix destruction and inflammatory cell response
52. Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model
53. Micro-methods for serial determinations of elastin metabolism parameters in blood plasma and serum
54. Aging of the vascular wall: Serum concentration of elastin peptides and elastase inhibitors in relation to cardiovascular risk factors. The EVA study
55. Comparison of elastin peptides concentrations in body fluids from healthy volunteers smokers and patients with chronic obstructive pulmonary disease
56. Micellar electrokinetic chromatography for the determination of urinary desmosine and isodesmosine in patients affected by chronic obstructive pulmonary disease
57. Serumelastin-peptides as a predictor of expansion of small abdominal aortic aneurysms
58. The association between cigarette smoking and abdominal aortic aneurysms
59. Inflammatory abdominal aortic aneurysms: A case control study
60. Prevalence of aortic aneurysm in men with history of inguinal hernia repair
61. Urinary desmosine excretion in smokers with and without rapid decline of lung function
62. Natural history of abdominal aortic aneurysm with and without coexisting chronic obstructive pulmonary disease
63. Chronic obstructive pulmonary disease and abdominal aortic aneurysms
64. Medial neovascularisation in abdominal aortic aneurysms: A histopathologic marker of aneurysmal degeneration with pathophysiologic implications
65. Angiogenesis is associated with mononuclear inflammatory cells in abdominal aortic aneurysms
66. Angiogenesis in abdominal aortic aneurysms
67. Molecular and cellular basis of myocardial angiogenesis
68. Matrix degrading proteases and angiogenesis during development and tumor formation
69. Inflammation and angiogenesis
70. Macrophages and angiogenesis
71. The role of inflammation in vascular diseases
72. Inflammation of the abdominal aortic aneurysm wall
73. Human abdominal aortic aneurysms. Immunophenotypic analysis suggestin an immune-mediated response
74. The role of inflammation in nonspecyfic abdominal aortic aneurysm disease
75. Inflammation, metalloproteinases, and increased proteolysis: An emerging pathophysiological paradigm in aortic aneurysm
76. Presence of the elastin-laminin receptor on human activated lymphocytes
77. Lymphocytes in human atherosclerotic plaque exhibit the elastin-laminin receptor: Potential role in atherogenesis
78. Granzymes: Exogenous proteinases that induce target cell apoptosis
79. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms
80. Vascular smooth muscle cell apoptosis in aneurysmal, occlusive and normal human aortas